Inhibrx Biosciences, Inc. INBX | $61.19B | 12.09 | 1.75M | 0% | +$0 | 98.07 | |
VistaGen Therapeutics, Inc. VTGN | $14.13M | 9.9 | 2.68M | 0% | +$0 | 0.02 | |
Adverum Biotechnologies, Inc. ADVM | $28.4M | 9.68 | 2.01M | New | +$28.4M | 0.05 | |
Astria Therapeutics, Inc. ATXS | $74.3M | 9.61 | 5.28M | New | +$74.3M | 0.12 | |
Aerovate Therapeutics, Inc. AVTE | $65.09M | 7.64 | 2.2M | 0% | +$0 | 0.1 |